S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
OTCMKTS:MRVFF

Nuvo Pharmaceuticals News Headlines

$0.62
0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.62
$0.62
50-Day Range
$0.62
$1.25
52-Week Range
$0.62
$1.41
Volume
N/A
Average Volume
801 shs
Market Capitalization
$7.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.32
Get Nuvo Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVFF and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Nuvo Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MRVFF
News Sentiment

0.76

0.30

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MRVFF Articles
This Week

1

0

MRVFF Articles
Average Week



Nuvo Pharmaceuticals (OTCMKTS:MRVFF) News Headlines Today

SourceHeadline
finance.yahoo.com logoMiravo Healthcare™ Announces First Quarter 2022 Results
finance.yahoo.com - May 16 at 8:53 AM
finance.yahoo.com logoMiravo Healthcare™ Provides an Update on the United States Pennsaid® 2% Business
finance.yahoo.com - May 12 at 7:50 AM
MarketBeat logoAnalyzing Nuvo Pharmaceuticals (MRVFF) and Its Rivals
americanbankingnews.com - May 12 at 1:48 AM
finance.yahoo.com logoMiravo Healthcare™ Announces First Quarter 2022 Results Release Date and Virtual Annual Meeting of Shareholders
finance.yahoo.com - May 2 at 7:48 AM
finance.yahoo.com logoMiravo Healthcare™ to Present at Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 19 at 7:42 AM
seekingalpha.com logoNuvo Pharmaceuticals; reports Q4 results
seekingalpha.com - March 29 at 9:12 PM
seekingalpha.com logoNuvo Pharmaceuticals Inc. 2021 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 28 at 3:48 PM
finance.yahoo.com logoMiravo Healthcare™ Announces 2021 and Fourth Quarter Results
finance.yahoo.com - March 28 at 8:00 AM
finance.yahoo.com logoMiravo Healthcare™ Announces Fourth Quarter 2021 Results Release Date and Conference Call Details
finance.yahoo.com - March 14 at 8:26 AM
finance.yahoo.com logoMiravo Healthcare™ Announces the Canadian Commercial Launch of Blexten® for Patients 4 Years of Age and Older*
finance.yahoo.com - March 1 at 4:49 PM
finance.yahoo.com logoMiravo Healthcare™ Announces Summary Judgment Ruling by the United States District Court for the District of New Jersey
finance.yahoo.com - February 28 at 9:09 AM
finance.yahoo.com logoMiravo Healthcare(TM) to Present at Q1 Virtual Investor Summit
finance.yahoo.com - February 28 at 9:09 AM
finance.yahoo.com logoMiravo Healthcare™ Named to 2022 OTCQX Best 50
finance.yahoo.com - January 24 at 8:59 AM
finance.yahoo.com logoMiravo Healthcare™ Announces Participation at the H.C. Wainwright Bioconnect Conference
finance.yahoo.com - January 6 at 12:00 PM
finance.yahoo.com logoKeynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
finance.yahoo.com - December 6 at 8:39 AM
finance.yahoo.com logoMiravo Healthcare™ Presents at the SNN Network Canada Virtual Event
finance.yahoo.com - November 24 at 8:18 AM
finance.yahoo.com logoMiravo Healthcare™ to Host Investor Webcast on December 2, 2021 at 2:00 p.m. ET
finance.yahoo.com - November 18 at 7:46 AM
finance.yahoo.com logoMiravo Healthcare™ Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 7 at 7:48 AM
finance.yahoo.com logoMiravo Healthcare™ Announces Receipt of Health Canada Notice of Compliance for the Pediatric Use of Blexten®
finance.yahoo.com - August 12 at 1:15 PM
finance.yahoo.com logoMiravo Healthcare™ Announces Second Quarter 2021 Results Release Date and Conference Call Details
finance.yahoo.com - July 26 at 9:26 AM
markets.businessinsider.com logoMiravo Healthcare™ Announces First Quarter 2021 Results
markets.businessinsider.com - May 17 at 8:54 AM
markets.businessinsider.com logoMiravo Healthcare™ to Present at Q2 Virtual Investor Summit
markets.businessinsider.com - May 11 at 9:59 AM
markets.businessinsider.com logoMiravo Healthcare™ Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of Shareholders
markets.businessinsider.com - May 3 at 7:57 AM
benzinga.com logoGlobal Over the Counter Drugs Market (2020 to 2025) - by Mode of Intake, Product, End-user and Geography
benzinga.com - April 30 at 9:54 AM
markets.businessinsider.com logoMiravo Healthcare™ to Present at Upcoming Investor Conferences
markets.businessinsider.com - April 9 at 8:20 AM
markets.businessinsider.com logoMiravo Healthcare to present at the Q1 Virtual Investor Summit
markets.businessinsider.com - March 11 at 9:48 AM
finance.yahoo.com logoEarnings Update: Here's Why Analysts Just Lifted Their Nuvo Pharmaceuticals Inc. (TSE:MRV) Price Target To CA$2.60
finance.yahoo.com - March 10 at 7:41 AM
finance.yahoo.com logoMiravo Healthcare™ Files Preliminary Base Shelf Prospectus
finance.yahoo.com - March 8 at 5:20 PM
reuters.com logoDr Reddy's loses bid to invalidate Horizon arthritis drug patents
reuters.com - February 17 at 10:36 PM
finance.yahoo.com logoMiravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST
finance.yahoo.com - January 14 at 7:28 PM
finance.yahoo.com logoMiravo Healthcare™ Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee
finance.yahoo.com - January 13 at 8:46 AM
finance.yahoo.com logoNuvo Pharmaceuticals® Announces Third Quarter 2020 Results
finance.yahoo.com - November 16 at 8:33 AM
finance.yahoo.com logoNuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details
finance.yahoo.com - November 2 at 7:33 AM
in.finance.yahoo.com logoNuvo Pharmaceuticals Inc. Regis (23N.SG)
in.finance.yahoo.com - October 10 at 1:05 PM
finance.yahoo.com logoNuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th
finance.yahoo.com - September 14 at 8:38 AM
finance.yahoo.com logoNuvo Pharmaceuticals® Announces Second Quarter 2020 Results
finance.yahoo.com - August 10 at 8:43 AM
finance.yahoo.com logoNuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders
finance.yahoo.com - May 12 at 4:24 PM
finance.yahoo.com logoNuvo Pharmaceuticals® Announces First Quarter 2020 Results
finance.yahoo.com - May 11 at 5:52 PM
finance.yahoo.com logoC-Suite At The Open: Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc., tells his Company's Story. Filmed on April 24, 2020
finance.yahoo.com - April 30 at 3:46 PM
www.bloomberg.com logoNuvo Pharmaceuticals™ Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent
www.bloomberg.com - April 26 at 12:15 AM
www.proactiveinvestors.com logoFull interview: Nuvo Pharmaceuticals subsidiary announces Takeda’s Cabpirin approved in Japan
www.proactiveinvestors.com - April 1 at 8:53 PM
finance.yahoo.com logoNuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th
finance.yahoo.com - March 23 at 8:36 AM
finance.yahoo.com logoEdited Transcript of NRI.TO earnings conference call or presentation 25-Feb-20 1:30pm GMT
finance.yahoo.com - March 9 at 6:50 PM
finance.yahoo.com logoNuvo Pharmaceuticals® Announces Health Canada Approves Suvexx™ For The Acute Treatment of Migraine
finance.yahoo.com - February 27 at 6:48 PM
ca.finance.yahoo.com logoNuvo Pharmaceuticals Inc. (NRI.TO)
ca.finance.yahoo.com - February 25 at 1:47 PM
finance.yahoo.com logoNuvo Pharmaceuticals® Announces 2019 and Fourth Quarter Results
finance.yahoo.com - February 25 at 8:46 AM
finance.yahoo.com logoSome Nuvo Pharmaceuticals (TSE:NRI) Shareholders Have Taken A Painful 85% Share Price Drop
finance.yahoo.com - February 18 at 7:53 AM
www.bloomberg.com logoNuvo Pharmaceuticals™ Receives Approval from German Regulatory Authorities to Conduct Pennsaid® 2% Phase 3 Trial for
www.bloomberg.com - February 11 at 7:00 PM
finance.yahoo.com logoNuvo Pharmaceuticals™ Responds to Market Activity
finance.yahoo.com - February 11 at 7:00 PM
www.bloomberg.com logoNuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Arale
www.bloomberg.com - February 10 at 11:25 PM
Get Nuvo Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVFF and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.